Polaris Group announced the signing of MOU with National Health Research Institutes of Taiwan for future collaboration. Cause of occurrence: Polaris Group and National Health Research Institutes of Taiwan announced the signing of MOU for future research collaboration in the field of mRNA, DNA, cancer vaccines, and cell therapy. In order to facilitate future collaboration, both parties agree to follow this MOU to enhance the research and development collaboration, consulting and technology transfer.

Any other matters that need to be specified: It takes considerable time and expenses to develop a new drug of which success can't be guaranteed. Investors shall bear such investment risk that warrants careful assessment before making investment decisions.